Agilon Health, Inc. (AGL) Investor Relations Documents

Agilon Health, Inc. (AGL) investor relations documents from the company's IR site: 4 presentations, 34 press releases; latest deck 2025-05-06. Read in-app with summaries. First-party data.

Agilon Health First Quarter 2025 Earnings Conference: Agilon health Q1 2025 earnings results report $1.53 billion in total revenue and $21 million in Adjusted EBITDA, with a path to break-even cash flow by 2027.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-06-23Press releaseagilon health to Participate in Upcoming Conferences
2026-02-25Press releaseagilon health Sets Date to Report Fourth Quarter and Full Year 2025 Financial Results
2025-05-06PresentationAgilon Health First Quarter 2025 Earnings Conference
2025-04-17Proxy statementProxy Statement (opens in new window)
2025-02-25Quarterly reportAgilon Health Fourth Quarter 2024 Earnings Conference
2024-11-19PresentationWolfe Research Healthcare Conference 2024
2024-06-04PresentationWilliam Blair 44th Annual Growth Stock Conference
2024-02-27Earnings deckagilon health Fourth Quarter 2023 Earnings Conference
Press releaseagilon health Sets Date to Report Second Quarter 2026 Financial Results
Press releaseagilon health Sets Date to Report First Quarter 2026 Financial Results
Press releaseagilon health Reports Second Quarter 2026 Results
Press releaseagilon health Reports First Quarter 2026 Results
Press releaseagilon health to Participate in the 8th Annual Evercore Healthcare Conference
Press releaseagilon health to Participate in TD Cowen’s 45th Annual Health Care Conference
Press releaseagilon health to Participate in BofA Securities 2025 Health Care Conference
Press releaseagilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference
Press releaseagilon health Sets Date to Report Third Quarter 2025 Financial Results
Press releaseagilon health Sets Date to Report Second Quarter 2025 Financial Results
Press releaseagilon health Sets Date to Report Fourth Quarter and Full Year 2024 Financial Results
Press releaseagilon health Sets Date to Report First Quarter 2025 Financial Results
Press releaseagilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook
Press releaseagilon health Reports Second Quarter 2025 Results
Press releaseagilon health Reports Fourth Quarter and Full Year Fiscal 2024 Results
Press releaseagilon health Reports First Quarter 2025 Results
Press releaseagilon health Announces Leadership Transition
Press releaseagilon Announces Receipt of Notice of Non-Compliance with the NYSE Continued Listing Standards
Press releaseagilon health to Participate in the 44th Annual Cowen Health Care Conference
Press releaseagilon health to Participate at 2024 Wells Fargo Healthcare Conference
Press releaseagilon health Sets Date to Report Third Quarter 2024 Financial Results
Press releaseagilon health Sets Date to Report Second Quarter 2024 Financial Results
Press releaseagilon health Sets Date to Report Fourth Quarter and Full Year 2023 Financial Results
Press releaseagilon health Sets Date to Report First Quarter 2024 Financial Results
Press releaseagilon health Reports Third Quarter 2024 Results
Press releaseagilon health Reports Second Quarter 2024 Results
Press releaseagilon health Reports Fourth Quarter 2023 Results
Press releaseagilon health Reports First Quarter 2024 Results
Press releaseagilon health Reports ACO REACH Model Results for 2023 Performance Year
Press releaseagilon health Provides 2023 Guidance Update, Initial 2024 View
Press releaseagilon health Names Jeff Schwaneke New Chief Financial Officer
Press releaseagilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

AGL overview · AGL earnings · AGL financials · AGL KPIs · AGL documents · AGL ownership · AGL peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.